A reduction in migraine frequency would be life-changing
Tomaro-Duchesneau C, LeValley SL, Roeth D, et al
The consultation itself is conducted by a licensed physician, but patients have no way to verify who that physician is before the visit
You should not take a GLP-1 drug if you have severe gastrointestinal conditions like inflammatory bowel disease (IBD) or gastroparesis or a personal or family history of multiple endocrine neoplasia 2A, multiple endocrine neoplasia 2B, medullary thyroid cancer, or pancreatitis
b) Nachhaltigkeit Whrend der STEP-1-Studienverlngerung [11] wurde nach 68 Wochen ein erheblicher Gewichtsverlust unter Semaglutid beobachtet, aber nach Absetzen des Medikaments trat Gewichtszunahme auf, siehe Abbildung 1
These alternatives typically show lower efficacy than GLP-1s but provide meaningful benefits at reduced cost